Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Heinz Reichmann; Andrew Lees; José Francisco Rocha; Diogo Magalhães; Patrício Soares-Da-Silva; Camille Carroll

doi:10.1186/s40035-020-00187-1

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Heinz Reichmann, Andrew Lees, José Francisco Rocha, Diogo Magalhães, Patrício Soares-Da-Silva^*, Camille Carroll

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

2 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Translational Neurodegeneration
Volume	9
Issue number	1
Early online date	4 Mar 2020
DOIs	https://doi.org/10.1186/s40035-020-00187-1
Publication status	Published - Dec 2020

Access to Document

10.1186/s40035-020-00187-1

Effectiveness and safety of opicapone in Parkinson (1)

Cite this

@article{c395e0b409744824a84812eb470a0e84,

title = "Effectiveness and safety of opicapone in Parkinson{\textquoteright}s disease patients with motor fluctuations: the OPTIPARK open-label study",

author = "Heinz Reichmann and Andrew Lees and Rocha, {Jos{\'e} Francisco} and Diogo Magalh{\~a}es and Patr{\'i}cio Soares-Da-Silva and Camille Carroll",

year = "2020",

month = dec,

doi = "10.1186/s40035-020-00187-1",

language = "English",

volume = "9",

journal = "Translational Neurodegeneration",

issn = "2047-9158",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

AU - Reichmann, Heinz

AU - Lees, Andrew

AU - Rocha, José Francisco

AU - Magalhães, Diogo

AU - Soares-Da-Silva, Patrício

AU - Carroll, Camille

PY - 2020/12

Y1 - 2020/12

U2 - 10.1186/s40035-020-00187-1

DO - 10.1186/s40035-020-00187-1

M3 - Article

SN - 2047-9158

VL - 9

JO - Translational Neurodegeneration

JF - Translational Neurodegeneration

IS - 1

ER -